Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder During Adolescence in the Primary Care Setting: A Concise Review

Overview

Journal J Adolesc Health

Publisher Elsevier

Specialty Pediatrics

Date 2016 May 23

PMID 27209327

Citations 6

Authors

Khyati Brahmbhatt

Donald M Hilty

Mina Hah

Jaesu Han

Kathy Angkustsiri

Julie B Schweitzer

Affiliations

Soon will be listed here.

Abstract

Attention deficit hyperactivity disorder (ADHD) is a chronic neurodevelopmental disorder with a worldwide prevalence of about 5% in school-age children. This review is intended to assist primary care providers (PCPs) in diagnosing and treating ADHD in adolescents. PubMed, PsychInfo, and Science Citation Index databases were searched from March 1990 to 2015 with the keywords: ADHD, primary care/pediatrics, and children/adolescents. Abstracts addressing diagnosis and/or treatment with 105 citations were identified including supplementary treatment guidelines/books. Adolescent ADHD presents with significant disturbances in attention, academic performance, and family relationships with unique issues associated with this developmental period. Diagnostic challenges include the variable symptom presentation during adolescence, complex differential diagnosis, and limited training and time for PCPs to conduct thorough evaluations. The evidence base for treatments in adolescence in comparison to those in children or adults with ADHD is relatively weak. Providers should be cognizant of prevention, early identification, and treatment of conditions associated with ADHD that emerge during adolescence such as substance use disorders. Adolescent ADHD management for the PCP is complex, requires further research, and perhaps new primary care psychiatric models, to assist in determining the optimal care for patients at this critical period.

Citing Articles

Advanced machine learning techniques reveal multidimensional EEG abnormalities in children with ADHD: a framework for automatic diagnosis.

Mao Y, Qi X, He L, Wang S, Wang Z, Wang F Front Psychiatry. 2025; 16:1475936.

PMID: 40027598 PMC: 11868104. DOI: 10.3389/fpsyt.2025.1475936.

Prevalence and Clinical Profile of Adults with ADHD Attending a Tertiary Care Hospital for Five Years.

Bedawi R, Al-Farsi Y, Mirza H, Al-Huseini S, Al-Mahrouqi T, Al-Kiyumi O Int J Environ Res Public Health. 2024; 21(5).

PMID: 38791781 PMC: 11121453. DOI: 10.3390/ijerph21050566.

Clinician Knowledge, Confidence, and Treatment Practices in Their Provision of Psychotherapy to Autistic Youth and Youth with ADHD.

Gallant C, Roudbarani F, Ibrahim A, Maddox B, Weiss J J Autism Dev Disord. 2022; 53(11):4214-4228.

PMID: 36076117 PMC: 10539421. DOI: 10.1007/s10803-022-05722-9.

Accurate Identification of ADHD among Adults Using Real-Time Activity Data.

Kaur A, Kahlon K Brain Sci. 2022; 12(7).

PMID: 35884638 PMC: 9312518. DOI: 10.3390/brainsci12070831.

A Phase 3, Placebo-Controlled Trial of Once-Daily Viloxazine Extended-Release Capsules in Adolescents With Attention-Deficit/Hyperactivity Disorder.

Nasser A, Liranso T, Adewole T, Fry N, Hull J, Busse G J Clin Psychopharmacol. 2021; 41(4):370-380.

PMID: 34181360 PMC: 8244935. DOI: 10.1097/JCP.0000000000001404.

References

Miller C, Newcorn J, Halperin J . Fading memories: retrospective recall inaccuracies in ADHD. J Atten Disord. 2009; 14(1):7-14. DOI: 10.1177/1087054709347189. View

Higa-McMillan C, Francis S, Rith-Najarian L, Chorpita B . Evidence Base Update: 50 Years of Research on Treatment for Child and Adolescent Anxiety. J Clin Child Adolesc Psychol. 2015; 45(2):91-113. DOI: 10.1080/15374416.2015.1046177. View

Walkup J, Stossel L, Rendleman R . Beyond rising rates: personalized medicine and public health approaches to the diagnosis and treatment of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2013; 53(1):14-6. DOI: 10.1016/j.jaac.2013.10.008. View

Somerville L . Special issue on the teenage brain: Sensitivity to social evaluation. Curr Dir Psychol Sci. 2014; 22(2):121-127. PMC: 3992953. DOI: 10.1177/0963721413476512. View

Roberts W, Milich R, Fillmore M . Reduced acute recovery from alcohol impairment in adults with ADHD. Psychopharmacology (Berl). 2013; 228(1):65-74. PMC: 3679354. DOI: 10.1007/s00213-013-3016-x. View

Wolraich M, Brown L, Brown R, DuPaul G, Earls M, Feldman H . ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2011; 128(5):1007-22. PMC: 4500647. DOI: 10.1542/peds.2011-2654. View

Clavenna A, Bonati M . Safety of medicines used for ADHD in children: a review of published prospective clinical trials. Arch Dis Child. 2014; 99(9):866-72. DOI: 10.1136/archdischild-2013-304170. View

Upadhyaya H . Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder. J Clin Psychiatry. 2008; 68 Suppl 11:23-30. View

Molina B, Hinshaw S, Eugene Arnold L, Swanson J, Pelham W, Hechtman L . Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication. J Am Acad Child Adolesc Psychiatry. 2013; 52(3):250-63. PMC: 3589108. DOI: 10.1016/j.jaac.2012.12.014. View

10.

Montano B . Diagnosis and treatment of ADHD in adults in primary care. J Clin Psychiatry. 2004; 65 Suppl 3:18-21. View

11.

Findling R, Biederman J, Wilens T, Spencer T, McGough J, Lopez F . Short- and long-term cardiovascular effects of mixed amphetamine salts extended release in children. J Pediatr. 2005; 147(3):348-54. DOI: 10.1016/j.jpeds.2005.03.014. View

12.

Lee S, Humphreys K, Flory K, Liu R, Glass K . Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review. Clin Psychol Rev. 2011; 31(3):328-41. PMC: 3180912. DOI: 10.1016/j.cpr.2011.01.006. View

13.

Tandon M, Tillman R, Spitznagel E, Luby J . Parental Warmth and Risks of Substance Use in Children with Attention-Deficit/Hyperactivity Disorder: Findings from a 10-12 Year Longitudinal Investigation. Addict Res Theory. 2014; 22(3):239-250. PMC: 4063351. DOI: 10.3109/16066359.2013.830713. View

14.

Ghanizadeh A, Zarei N . Are GPs adequately equipped with the knowledge for educating and counseling of families with ADHD children?. BMC Fam Pract. 2010; 11:5. PMC: 2822770. DOI: 10.1186/1471-2296-11-5. View

15.

Biederman J, Spencer T, Wilens T . Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder. Int J Neuropsychopharmacol. 2004; 7(1):77-97. DOI: 10.1017/S1461145703003973. View

16.

Goodman D, Surman C, Scherer P, Salinas G, Brown J . Assessment of physician practices in adult attention-deficit/hyperactivity disorder. Prim Care Companion CNS Disord. 2012; 14(4). PMC: 3505127. DOI: 10.4088/PCC.11m01312. View

17.

Patros C, Hudec K, Alderson R, Kasper L, Davidson C, Wingate L . Symptoms of attention-deficit/hyperactivity disorder (ADHD) moderate suicidal behaviors in college students with depressed mood. J Clin Psychol. 2013; 69(9):980-93. DOI: 10.1002/jclp.21994. View

18.

Buitelaar J, Wilens T, Zhang S, Ning Y, Feldman P . Comparison of symptomatic versus functional changes in children and adolescents with ADHD during randomized, double-blind treatment with psychostimulants, atomoxetine, or placebo. J Child Psychol Psychiatry. 2009; 50(3):335-42. DOI: 10.1111/j.1469-7610.2008.01960.x. View

19.

Hilty D, Ferrer D, Burke Parish M, Johnston B, Callahan E, Yellowlees P . The effectiveness of telemental health: a 2013 review. Telemed J E Health. 2013; 19(6):444-54. PMC: 3662387. DOI: 10.1089/tmj.2013.0075. View

20.

Fischer M, Barkley R, Smallish L, Fletcher K . Young adult follow-up of hyperactive children: self-reported psychiatric disorders, comorbidity, and the role of childhood conduct problems and teen CD. J Abnorm Child Psychol. 2002; 30(5):463-75. DOI: 10.1023/a:1019864813776. View